Ignite Creation Date:
2025-12-25 @ 3:00 AM
Ignite Modification Date:
2026-03-01 @ 10:09 AM
Study NCT ID:
NCT00629733
Status:
COMPLETED
Last Update Posted:
2011-06-08
First Post:
2008-02-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of a New Ultra Low Molecular Weight Heparin (RO-14) Administered Subcutaneously Increasing Single-doses to Healthy Male Volunteers
Sponsor:
Rovi Pharmaceuticals Laboratories
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-12
Start Date Type:
None
Primary Completion Date:
2007-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-12
Completion Date Type:
ACTUAL
First Submit Date:
2008-02-15
First Submit QC Date:
None
Study First Post Date:
2008-03-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-06-07
Last Update Post Date:
2011-06-08
Last Update Post Date Type:
ESTIMATED